We offer assay development and assay validation services for Immunogenecity assessment of Biotherapeutics. We are capable of developing highly sensitive ELISA based screening methods as well as cell-based Neutralizing Antibody Assays that confirms screening results.

The actual testing of the Clinical samples can be performed in a GLP facility. The material can be transferred to this facility.